Complete clearance and Psoriasis Area and Severity Index response for brodalumab and ustekinumab by previous treatment history in AMAGINE-2 and AMAGINE-3.
Kristian ReichJ B HansenLluis L PuigMaria-Polina KonstantinouR B WarrenPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2021)
Treatment with brodalumab was associated with higher levels of complete clearance and greater cumulative benefit over time compared with ustekinumab, in patients with moderate-to-severe psoriasis, regardless of prior treatment experience.